Stoke Therapeutics, Inc. (STOK) stock
STOKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30173% above fair value
$26.69+0.28 (+1.06%)
Close on Nov 18, 2026Market cap $1.72BP/E –Yield –
Stoke Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Stoke Therapeutics's market cap was $1.73B on Nov 11, 2026, against $1.70B a year earlier. Over the last 5 years it ranged from $167.87M to $2.15B, with a median of $619.66M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.73B | -1.0% |
| 2025 | Dec 31, 2025 | $1.75B | +199.6% |
| 2024 | Dec 31, 2024 | $583.94M | +150.6% |
| 2023 | Dec 29, 2023 | $232.98M | -36.0% |
| 2022 | Dec 30, 2022 | $363.91M | -58.8% |
| 2021 | Dec 31, 2021 | $882.36M | -57.3% |
| 2020 | Dec 31, 2020 | $2.07B | +122.9% |
| 2019 | Dec 31, 2019 | $926.75M | – |
See a number that looks wrong?